Vioxx Lawyers Canada

Canada Lawyers Represent Hundreds of Canadians Injured by Vioxx

Our law firm represents more than 200 Canadians who suffered heart attacks, strokes or blood clots while using Vioxx. This site is updated frequently with updates on our firm's progress in helping those injured by Vioxx and the latest news concerning the litigation.

Our lawyers want to help you if you have been injured or lost a loved one as a result of Vioxx. Because the law limits the amount of time an injured person has to sue for injuries caused by defective pharmaceuticals like Vioxx, you should contact us immediately.

Greg Monforton Reacts to $4.85 Billion Vioxx Settlement

greg monforton

November 9, 2007—Greg Monforton today reacted to the U.S. $4.85 billion Vioxx settlement reached with Merck & Co.

Monforton’s office has fielded close to 4,000 inquiries from across Canada from people with concerns that they suffered injury by ingesting Vioxx.  Ultimately, Monforton agreed to take on over 300 individual cases involving Canadians from all provinces.  Monforton said that all of his firm’s Vioxx clients have suffered either heart attack or stroke, resulting in serious injuries and in many cases, death. 

Click here to read the full press release.

Jury Rules Against Merck in Vioxx Lawsuit

vioxx lawsuit

August 17, 2006—A New Orleans jury found that Merck was responsible for the heart attack suffered by a former FBI agent who had taken Vioxx for more than two years.

Jurors concluded that Merck "knowingly misrepresented or failed to disclose" important information about the safety profile of Vioxx. Jurors further found that Merck "acted in wanton, malicious, willful or reckless disregard for the plaintiff's rights."

Jurors award Gerald Barnett $50 million in compensatory damages and an additional $1 million in punitive damages. The trial had been postponed after Barnett was forced to undergo surgery to insert a stent in order to open one of his arteries.

New Jersey Jury Awards $13.5 Million to Vioxx Victim


April 5, 2006—A New Jersey jury found Merck responsible for the heart attack of a 77 year-old Vioxx user. The jury awarded John McDarby $4.5 million in compensatory damages while concluding that Merck failed to adequately warn about cardiovascular risk factors. This was the first trial involving long-term use of Vioxx.

The jury also awarded $9 million in punitive damages to John McDarby, finding that Merck had knowingly withheld information from the company. The jury concluded that the company's conduct was "wanton and willful."

The same jury rejected similar claims brought by a 60 year-old man, concluding Vioxx was not a factor in his heart attack.

In the first Vioxx lawsuit to reach trial, a Texas jury found Merck responsible for the death of a 59 year-old man who had been taking Vioxx prior to suffering a heart attack. The jury returned a multi-million dollar verdict in favor of the man's family.

Vioxx Recall

vioxx recall

September 30, 2004—Merck & Co. announced an immediate recall of Vioxx after a clinical study indicated a significantly elevated risk of heart attacks, strokes, and other serious side effects.

Vioxx was approved in Canada in 1999 and was the most prescribed drug in Canada for the treatment of arthritis. More than 3.36 million prescriptions were filled in Canada in 2003.

Researchers Concerned with Vioxx Heart Risk


In June 2001, the Journal for the American Medical Association (JAMA) published a study reporting that use of Vioxx may lead to serious kidney problems. A separate article published later that year suggested Vioxx may significantly increase the risk of cardiovascular problems.

Although the U.S. FDA implemented labeling changes in 2002 as a result of numerous studies that found significant risks with Vioxx, the manufacturer did not issue a recall until September 2004. Merck & Co. continued to actively promote the drug while downplaying the significance of negative reports about its safety.

Recent reports from the FDA indicate as many as 27,000 people may have suffered a heart attack or sudden cardiac death as a result of Vioxx. Another researcher with the FDA pins the number as high as 130,000.

Vioxx Lawyers Canada

vioxx lawyers canada

Greg Monforton and Partners is handling legal claims against Merck on behalf of Canadians injured by the arthritis drug Vioxx. We currently represent more than two hundred people who suffered heart attacks, blood clots and strokes after using Vioxx.

If you or a loved one has been injured as a result of Vioxx, we encourage you to contact us. We are representing clients throughout Canada in lawsuits against Merck. If you need an American lawyer click here for a Personal Injury Lawyer who Specializes in Pharmaceutical cases.

For free answers to your questions about the Vioxx lawsuit, please complete our online form.

Current Consumer Cases

Contact Us


About Our Lawyers

We are committed to protecting the rights of individuals injured by dangerous pharmaceuticals. The firm never represents insurance companies or product manufacturers. We only help people.

In the Press

Greg Monforton was featured in an article discussing the potential effects of the recent Vioxx jury award on cases filed by Canadians.

The article, titled Vioxx Award Good News for Canadian Lawsuits, appeared in the Canadian Medical Association Journal.

Vioxx News

Merck Wins Extension to Appeal Vioxx Certification in Ontario
May 11, 2009
Doctor Admits Pain Studies Were Frauds, Hospital Says
The New York Times
March 10, 2009
Merck to Pay $4.85B US for Vioxx Settlements
CBC News
November 9, 2007
Greg Monforton Reacts to $4.85 Billion Vioxx Settlement
Greg Monforton and Partners
November 9, 2007

Vioxx Lawsuit

Our firm has compiled important information on the latest developments in the Vioxx lawsuit.

We encourage you to visit the Vioxx news page for more details on the Vioxx recall and our efforts in representing hundreds of Canadians injured by Vioxx.